These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 29679304)

  • 41. Updating the relationship between hyperhomocysteinemia lowering therapy and cardiovascular events.
    Cheng X
    Cardiovasc Ther; 2013 Aug; 31(4):e19-26. PubMed ID: 23082962
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of homocysteine lowering by 5-methyltetrahydrofolate on redox status in hyperhomocysteinemia.
    Caruso R; Campolo J; Sedda V; De Chiara B; Dellanoce C; Baudo F; Tonini A; Parolini M; Cighetti G; Parodi O
    J Cardiovasc Pharmacol; 2006 Apr; 47(4):549-55. PubMed ID: 16680068
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Causes of hyperhomocysteinemia and its pathological significance.
    Kim J; Kim H; Roh H; Kwon Y
    Arch Pharm Res; 2018 Apr; 41(4):372-383. PubMed ID: 29552692
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease.
    Clarke R; Collins R
    J Cardiovasc Risk; 1998 Aug; 5(4):249-55. PubMed ID: 9919473
    [No Abstract]   [Full Text] [Related]  

  • 45. [Hyperhomocysteinemia: a risk factor for arterial and venous thrombosis].
    Wuillemin WA; Solenthaler M
    Vasa; 1999 Aug; 28(3):151-5. PubMed ID: 10483317
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Hyperhomocysteinemia in patients with cardiovascular disease].
    Baszczuk A; Kopczyński Z
    Postepy Hig Med Dosw (Online); 2014 Jan; 68():579-89. PubMed ID: 24864108
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Homocysteine, a new crucial element in the pathogenesis of uremic cardiovascular complications.
    Perna AF; Ingrosso D; Castaldo P; De Santo NG; Galletti P; Zappia V
    Miner Electrolyte Metab; 1999; 25(1-2):95-9. PubMed ID: 10207268
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rationale and design for the CARDIOVIT Study (Cardiovit, Atherosclerotic vascular disease and hypeRhomocysteinemia: an epiDemiological study in Indians, additionally evaluating the effect of Oral VITamin supplementation).
    Shenoy KT; Lena KB; Sali N; Syam S; Shenoy ST; Rajadhyaksha VD; Pai GP; Shaikh AA;
    Curr Med Res Opin; 2006 Apr; 22(4):641-8. PubMed ID: 16684424
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Plasma homocysteine levels in patients with ischemic heart disease].
    Márk L; Erdei F; Márki-Zay J; Nagy E; Kondacs A; Katona A
    Orv Hetil; 2001 Jul; 142(30):1611-5. PubMed ID: 11519232
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of vitamin B12 and folic acid supplementation on biomarkers of endothelial function and inflammation among elderly individuals with hyperhomocysteinemia.
    van Dijk SC; Enneman AW; Swart KM; van Wijngaarden JP; Ham AC; de Jonge R; Blom HJ; Feskens EJ; Geleijnse JM; van Schoor NM; Dhonukshe-Rutten RA; de Jongh RT; Lips P; de Groot LC; Uitterlinden AG; van den Meiracker TH; Mattace-Raso FU; van der Velde N; Smulders YM
    Vasc Med; 2016 Apr; 21(2):91-8. PubMed ID: 26774115
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Betaine supplementation decreases post-methionine hyperhomocysteinemia in chronic renal failure.
    McGregor DO; Dellow WJ; Robson RA; Lever M; George PM; Chambers ST
    Kidney Int; 2002 Mar; 61(3):1040-6. PubMed ID: 11849459
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Homocysteine and cardiovascular risk].
    Lutteri L; Chapelle JP; Gielen J
    Rev Med Liege; 1999 Jun; 54(6):541-7. PubMed ID: 10446525
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hyperhomocysteinemia and related factors in 600 hospitalized elderly subjects.
    Ventura P; Panini R; Verlato C; Scarpetta G; Salvioli G
    Metabolism; 2001 Dec; 50(12):1466-71. PubMed ID: 11735095
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Homocysteine in lipoprotein apheresis patients--retrospective data analysis in apheresis center of a university hospital.
    Tselmin S; Rodionov RN; Müller G; Bornstein S; Julius U
    Atheroscler Suppl; 2013 Jan; 14(1):123-8. PubMed ID: 23357153
    [TBL] [Abstract][Full Text] [Related]  

  • 55. POSITIVE EFFECT OF BETAINE-ARGININE SUPPLEMENT ON IMPROVED HYPERHOMOCYSTEINEMIA TREATMENT IN MARRIED COUPLES WITH REPRODUCTIVE DISORDERS.
    Rossokha Z; Fishchuk L; Sheyko L; Medvedieva N; Gorovenko N
    Georgian Med News; 2020 Dec; (309):22-28. PubMed ID: 33526724
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exercise prevents hyperhomocysteinemia in a dietary folate-restricted mouse model.
    Neuman JC; Albright KA; Schalinske KL
    Nutr Res; 2013 Jun; 33(6):487-93. PubMed ID: 23746565
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hyperhomocysteinemia induced by guanidinoacetic acid is effectively suppressed by choline and betaine in rats.
    Setoue M; Ohuchi S; Morita T; Sugiyama K
    Biosci Biotechnol Biochem; 2008 Jul; 72(7):1696-703. PubMed ID: 18603787
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The methionine-homocysteine cycle and its effects on cognitive diseases.
    Miller AL
    Altern Med Rev; 2003 Feb; 8(1):7-19. PubMed ID: 12611557
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Disturbances of homocysteine metabolism as a risk factor of cardiovascular diseases development: effect on prognosis and possibilities of correction with drugs].
    Shakhmatova OO; Komarov AL; Panchenko EP
    Kardiologiia; 2010; 50(1):42-50. PubMed ID: 20144157
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hyperhomocysteinemia in Cardiovascular Diseases: Revisiting Observational Studies and Clinical Trials.
    Guéant JL; Guéant-Rodriguez RM; Oussalah A; Zuily S; Rosenberg I
    Thromb Haemost; 2023 Mar; 123(3):270-282. PubMed ID: 36170884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.